HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chattem Icy Hot ads

This article was originally published in The Tan Sheet

Executive Summary

Q3 launch of Icy Hot Back Patch will be supported with $12 mil. TV, print ad campaign featuring Los Angeles Lakers basketball star Shaquille O'Neal; initiative is expected to spur topical analgesic sales growth in second half, President & COO Alec Taylor says during March 20 analysts call. Chattem has said the line extension could generate annual sales of $6 mil.-$8 mil. (1"The Tan Sheet" Jan. 27, 2003, p. 6). Firm's Q1 revenue jumps 20.7% to $58.4 mil., bolstered by 38% rise in Selsun Blue sales, along with double-digit gains by Icy Hot, pHisoderm, Garlique, Chattanooga, Tenn.-based firm reports. International revenues leap 89% in first quarter, "led by sales of Selsun Blue and the continuing strength of Gold Bond in Canada." Chattem's net income reached $4.6 mil. versus a loss of $6.5 mil. in year-ago period...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS129533

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel